Jason C. Barnett

1.2k total citations
33 papers, 911 citations indexed

About

Jason C. Barnett is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Jason C. Barnett has authored 33 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Reproductive Medicine, 15 papers in Obstetrics and Gynecology and 10 papers in Surgery. Recurrent topics in Jason C. Barnett's work include Endometrial and Cervical Cancer Treatments (14 papers), Ovarian cancer diagnosis and treatment (13 papers) and Uterine Myomas and Treatments (5 papers). Jason C. Barnett is often cited by papers focused on Endometrial and Cervical Cancer Treatments (14 papers), Ovarian cancer diagnosis and treatment (13 papers) and Uterine Myomas and Treatments (5 papers). Jason C. Barnett collaborates with scholars based in United States, Japan and South Korea. Jason C. Barnett's co-authors include Laura J. Havrilesky, Jennifer M. Wu, Evan R. Myers, Andrew Berchuck, Charles A. Leath, Angeles Alvarez Secord, Charles D. Scales, Neil T. Phippen, Susan K. Murphy and Paula S. Lee and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and Clinical Cancer Research.

In The Last Decade

Jason C. Barnett

33 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason C. Barnett United States 18 350 295 268 211 136 33 911
Akiva P. Novetsky United States 20 410 1.2× 393 1.3× 221 0.8× 282 1.3× 213 1.6× 48 1.3k
Leslie R. Boyd United States 19 306 0.9× 247 0.8× 298 1.1× 243 1.2× 188 1.4× 60 949
Anil Tailor United Kingdom 22 692 2.0× 640 2.2× 257 1.0× 123 0.6× 88 0.6× 63 1.3k
Wolfgang Janni Germany 22 109 0.3× 296 1.0× 201 0.8× 350 1.7× 220 1.6× 88 1.2k
François Planchamp France 14 749 2.1× 853 2.9× 450 1.7× 277 1.3× 63 0.5× 39 1.3k
Joel Clemmer United States 16 643 1.8× 641 2.2× 265 1.0× 194 0.9× 64 0.5× 40 949
Thomas L. Riley United States 15 365 1.0× 184 0.6× 199 0.7× 492 2.3× 160 1.2× 27 1.5k
Scott Kamelle United States 15 234 0.7× 410 1.4× 226 0.8× 162 0.8× 61 0.4× 23 733
Tsuyoshi Takiuchi Japan 17 247 0.7× 455 1.5× 74 0.3× 148 0.7× 173 1.3× 60 907
Nathaniel Jones United States 14 159 0.5× 161 0.5× 68 0.3× 200 0.9× 84 0.6× 44 524

Countries citing papers authored by Jason C. Barnett

Since Specialization
Citations

This map shows the geographic impact of Jason C. Barnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason C. Barnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason C. Barnett more than expected).

Fields of papers citing papers by Jason C. Barnett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason C. Barnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason C. Barnett. The network helps show where Jason C. Barnett may publish in the future.

Co-authorship network of co-authors of Jason C. Barnett

This figure shows the co-authorship network connecting the top 25 collaborators of Jason C. Barnett. A scholar is included among the top collaborators of Jason C. Barnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason C. Barnett. Jason C. Barnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Bao, et al.. (2018). A randomized controlled trial to determine whether a video presentation improves informed consent for hysterectomy. American Journal of Obstetrics and Gynecology. 219(3). 277.e1–277.e7. 37 indexed citations
2.
Phippen, Neil T., Laura J. Havrilesky, Jason C. Barnett, et al.. (2016). Does Routine Posttreatment PET/CT Add Value to the Care of Women With Locally Advanced Cervical Cancer?. International Journal of Gynecological Cancer. 26(5). 944–950. 5 indexed citations
3.
4.
Miller, Caela, et al.. (2016). Is FDA Approved Bevacizumab Cost-Effective in the Setting of Platinum-Resistant Recurrent Ovarian Cancer? [18]. Obstetrics and Gynecology. 127(Supplement 1). 6S–7S. 2 indexed citations
5.
Havrilesky, Laura J., Michaela A. Dinan, Lesley H. Curtis, et al.. (2015). Costs, Effectiveness, and Workload Impact of Management Strategies for Women With an Adnexal Mass. Obstetrical & Gynecological Survey. 70(4). 253–255. 4 indexed citations
6.
Barnett, Jason C., et al.. (2015). Laparoscopic Staging of Ovarian Immature Teratomas: A Report on Three Cases. Military Medicine. 180(3). e365–e368. 1 indexed citations
7.
Lee, Jung‐Yun, David E. Cohn, Younhee Kim, et al.. (2014). The cost-effectiveness of selective lymphadenectomy based on a preoperative prediction model in patients with endometrial cancer: Insights from the US and Korean healthcare systems. Gynecologic Oncology. 135(3). 518–524. 9 indexed citations
8.
Phippen, Neil T., Charles A. Leath, Laura J. Havrilesky, & Jason C. Barnett. (2014). Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: Is it cost-effective?. Gynecologic Oncology. 136(1). 43–47. 20 indexed citations
9.
Havrilesky, Laura J., Michaela A. Dinan, Lesley H. Curtis, et al.. (2014). Costs, Effectiveness, and Workload Impact of Management Strategies for Women With an Adnexal Mass. JNCI Journal of the National Cancer Institute. 107(1). 322–322. 17 indexed citations
10.
Secord, Angeles Alvarez, Jason C. Barnett, Jonathan A. Ledermann, et al.. (2013). Cost-Effectiveness of BRCA1 and BRCA2 Mutation Testing to Target PARP Inhibitor Use in Platinum-Sensitive Recurrent Ovarian Cancer. International Journal of Gynecological Cancer. 23(5). 846–852. 18 indexed citations
11.
Phippen, Neil T., Jason C. Barnett, William J. Lowery, Caela Miller, & Charles A. Leath. (2013). Surgical outcomes and national comprehensive cancer network compliance in advanced ovarian cancer surgery in a low volume military treatment facility. Gynecologic Oncology. 131(1). 158–162. 21 indexed citations
12.
Phippen, Neil T., Charles A. Leath, Caela Miller, et al.. (2013). Are supportive care-based treatment strategies preferable to standard chemotherapy in recurrent cervical cancer?. Gynecologic Oncology. 130(2). 317–322. 9 indexed citations
13.
14.
Barnett, Jason C., Laura J. Havrilesky, Nicole D. Fleming, et al.. (2011). Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer. American Journal of Obstetrics and Gynecology. 205(2). 143.e1–143.e6. 22 indexed citations
15.
16.
Havrilesky, Laura J., et al.. (2010). Projecting the Need for Gynecologic Oncologists for the Next 40 Years. Obstetrics and Gynecology. 116(6). 1366–1372. 28 indexed citations
17.
Barnett, Jason C., et al.. (2010). Cost Comparison Among Robotic, Laparoscopic, and Open Hysterectomy for Endometrial Cancer. Obstetrics and Gynecology. 116(3). 685–693. 139 indexed citations
18.
Matsumura, Noriomi, Zhiqing Huang, Tsukasa Baba, et al.. (2009). Yin Yang 1 Modulates Taxane Response in Epithelial Ovarian Cancer. Molecular Cancer Research. 7(2). 210–220. 48 indexed citations
19.
Berchuck, Andrew, Edwin S. Iversen, Jingqin Luo, et al.. (2009). Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome. Clinical Cancer Research. 15(7). 2448–2455. 60 indexed citations
20.
Barnett, Jason C., Sarah M. Bean, John Nakayama, et al.. (2009). High Poly(Adenosine Diphosphate-Ribose) Polymerase Expression and Poor Survival in Advanced-Stage Serous Ovarian Cancer. Obstetrics and Gynecology. 115(1). 49–54. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akiva P. Novetsky Breakdown of academic impact, for papers by Leslie R. Boyd Breakdown of academic impact, for papers by Anil Tailor Breakdown of academic impact, for papers by Wolfgang Janni Breakdown of academic impact, for papers by François Planchamp Breakdown of academic impact, for papers by Joel Clemmer Breakdown of academic impact, for papers by Thomas L. Riley Breakdown of academic impact, for papers by Scott Kamelle Breakdown of academic impact, for papers by Tsuyoshi Takiuchi Breakdown of academic impact, for papers by Nathaniel Jones
Rankless by CCL
2026